Related Experiment Video
Updated: Jul 15, 2025
Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Published on: October 21, 2021
Single cell sequencing technology and its application in Hypoxic ischemic encephalopathy research
Ting-Bao Chen1, Hong-Su Zhou2,3, Liu-Lin Xiong4,3
1Laboratory Zoology Department Kunming Medical University Kunming Yunnan China.
Insights
Hypoxic ischemic encephalopathy (HIE) poses significant risks to newborns. Single cell sequencing (SCS) offers novel insights into HIE
Area of Science:
- Neuroscience
- Genomics
- Neonatal Medicine
Background:
- Hypoxic ischemic encephalopathy (HIE) is a leading cause of neonatal mortality and long-term neurological disability.
- Current therapeutic strategies for HIE are limited, necessitating a deeper understanding of its pathological mechanisms.
- Irreversible damage to the neonatal nervous system can occur if timely therapeutic interventions are not implemented.
Purpose of the Study:
- To elucidate the pathological mechanisms underlying HIE.
- To explore the role of single cell sequencing (SCS) in understanding HIE.
- To investigate the function of microglia in HIE and identify potential therapeutic targets.
Main Methods:
- Review of existing literature on HIE and single cell sequencing (SCS).
- Analysis of SCS applications in studying cellular heterogeneity in HIE.
- Focus on the role of microglia in the context of HIE.
Main Results:
- Single cell sequencing (SCS) provides unprecedented resolution for studying cellular heterogeneity in HIE.
- SCS enables a deeper understanding of the molecular and cellular events during HIE onset and progression.
- Microglia play a critical role in HIE pathogenesis, with SCS offering new avenues to explore their functions.
Conclusions:
- SCS is a powerful tool for advancing basic research and precision medicine in HIE.
- Further research using SCS is crucial for uncovering unknown mechanisms of HIE.
- Identifying and understanding the role of microglia in HIE may lead to the development of novel therapeutic strategies.
Abstract:
Hypoxic ischemic encephalopathy (HIE) is the common etiology of neonatal morbidity and mortality, which exerts a negative seriously influence for the growth and development of children, and even threatens their life. Therapeutic methods are timely not adopted, it will cause serious irreversible damage to the neonatal nervous system. As no promising therapeutic strategies exist currently, it is important to elucidate the pathological mechanism for HIE, which requires us to explore the nucleic acid molecules, protein, and cell function in HIE patients, and to understand the process of the onset and progression, then research and invent better treatment methods and therapeutic drugs. Single cell sequencing (SCS) exhibits an distinctive advantages in cells research because of the particularity of each cell. This method solves an puzzle about heterogeneit, which could not be solved with multi cell sample research, and provides a new idea and perspective for the un-elucidated and events further analyzed, such as the behaviors, mechanisms and the relationship between single cell and organism in cell population. It also plays an extremely significant role in the basic research and precision medicine. Some studies have suggested that SCS serves a vital function in the study of HIE. Therefore, this review is aim to elaborate SCS and hypoxic-ischemic brain injury, and trace the role of microglia in HIE, and prospect its unknown and undiscovered mechanism by SCS.
